Literature DB >> 11297910

Renal function and renal disease in the elderly: Part I.

W J. Mulder1, H F.P. Hillen.   

Abstract

In all industrialized countries, life expectancy has risen in the past 100 years. The incidence of elderly patients reaching end-stage renal disease (ESRD) and requiring renal replacement therapy has also increased. During the past few decades, the pattern of ESRD has changed significantly with the emerging predominance of elderly patients. The causes of this phenomenon are manifold and include an increasing number of chronic diseases typical of the 'third age', such as type 2 diabetes mellitus and vascular disease. In many species, a consequence of aging includes deterioration of renal function, partly due to structural alterations, and partly as the result of a diminishing blood flow. In humans, the aging kidney is characterized by modifications resulting from organic and functional disturbances. In particular, type 2 diabetes mellitus has emerged as an important condition, the microvascular and macrovascular complications of which are a common cause of morbidity and mortality in older patients. In part I of this review, the morphological and functional changes of the aging kidney will be reviewed, as well as the pathological conditions leading to the loss of renal function in the elderly.

Entities:  

Year:  2001        PMID: 11297910     DOI: 10.1016/s0953-6205(01)00121-2

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

1.  Calpain 10 is required for cell viability and is decreased in the aging kidney.

Authors:  Marisa D Covington; David D Arrington; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

2.  Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patients.

Authors:  Henrik Agersø; Lotte Seiding Larsen; Anders Riis; Ulf Lövgren; Mats O Karlsson; Thomas Senderovitz
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 3.  Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals.

Authors:  Gary Ginsberg; Dale Hattis; Abel Russ; Babasaheb Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

Review 4.  Beneficial Effects of Caloric Restriction on Chronic Kidney Disease in Rodent Models: A Meta-Analysis and Systematic Review.

Authors:  Xiao-Meng Xu; Guang-Yan Cai; Ru Bu; Wen-Juan Wang; Xue-Yuan Bai; Xue-Feng Sun; Xiang-Mei Chen
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

5.  Age-related changes in urinary protein excretion in relation to indices of renal function in Wistar rats.

Authors:  Olaoluwa Sesan Olukiran; Rufus Ojo Akomolafe; Olutosin Samuel Ilesanmi; Christian Eseigbe Imafidon; Quadri Kunle Alabi
Journal:  Animal Model Exp Med       Date:  2018-11-14

6.  Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.

Authors:  Olivier Devuyst; Luca Rampoldi; Matteo Trudu; Sylvie Janas; Chiara Lanzani; Huguette Debaix; Céline Schaeffer; Masami Ikehata; Lorena Citterio; Sylvie Demaretz; Francesco Trevisani; Giuseppe Ristagno; Bob Glaudemans; Kamel Laghmani; Giacomo Dell'Antonio; Johannes Loffing; Maria P Rastaldi; Paolo Manunta
Journal:  Nat Med       Date:  2013-11-03       Impact factor: 53.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.